Navigation Links
Genomic Health Announces Third Quarter 2011 Financial Results and Business Progress
Date:11/1/2011

for the same period in 2010 of $4.5 million.

In the third quarter of 2011, more than 16,890 Oncotype DX test results were delivered, an increase of 15 percent, compared with 14,730 test results delivered in the third quarter of 2010.

Financial Results for Nine Months Ended September 30, 2011Total revenue for the nine months ended September 30, 2011 was $152.7 million, compared with $131.0 million for the first nine months of 2010. Product revenue for the nine months ended September 30, 2011 was $151.6 million, compared with $128.6 million for the first nine months of 2010, an increase of 18 percent.

Net income was $5.3 million for the nine months ended September 30, 2011, compared with net income of $2.6 million for the first nine months of 2010. Basic net income per share was $0.18 and diluted net income per share was $0.17 for the nine months ended September 30, 2011, compared with basic and diluted net income per share of $0.09 for the first nine months of 2010.

Cash and cash equivalents and investments in marketable securities at September 30, 2011 were $87.4 million compared with $76.8 million at December 31, 2010.

Financial Guidance Update"Due to ongoing strength and leverage in our business, continued reimbursement success, and an amendment to a PCR licensing arrangement, we are raising our full year 2011 net income guidance from $3-$5 million to approximately $8 million," said Dean Schorno, Chief Financial Officer of Genomic Health.  

Quarterly Highlights Oncotype DX Breast Cancer Commercial Progress

  • Established reimbursement contract with the Irish HSE National Cancer Control Programme, the country's public insurer covering approximately half the population of Ireland.  This coverage for lymph-node-negative, estrogen receptor-positive breast cancer patients makes Ireland the first European country to provide full public reimbursement
    '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    3. Personalized Medicine - The Genomic Revolution in Cardiac Care
    4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
    5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
    6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
    7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
    8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
    9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
    10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
    11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... California , September 1, 2015 ... is segmented on the basis of sectors, products ... chronic diseases globally coupled with the increasing demand ... diseases are expected to propel the growth for ... manage biological information efficiently is known as bioinformatics. ...
    (Date:9/1/2015)... Aug. 31, 2015 Research and Markets ( ... "Regulatory Affairs for Support Staff (London, UK - September ... This two day course provides an introduction to ... and has been designed specifically for those working in ... gain an overview of EU regulatory procedures required to ...
    (Date:9/1/2015)... 2015 - The ... egistry data presented at ESC Congress ... the evolution of manag ing AF in ... -   The first-ever two-year outcomes from the Global Anticoagulant ... expose that all-cause death was the most frequent major event in more than ...
    Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
    (Date:9/1/2015)... ... , ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion women’s ... buys an Earth Brand shoe will be given an opportunity to plant a ... a nonprofit dedicated to planting more trees. Earth Brands products represent contemporary designs ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... not managed, stress created from everyday life changes can lead to very serious, ... provide support for coping with stress. Herbal supplement manufacturer MediHerb has ...
    (Date:9/1/2015)... ... 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive ... Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each of ... work for Calvary, and two junior counselors who were campers themselves just a few ...
    (Date:9/1/2015)... ... 2015 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has ... LATINA Style 50 Report that recognizes companies that provide the best career opportunities for ... climbs from number 24 to 21 of the 50 Best Companies for Latinas. The ...
    Breaking Medicine News(10 mins):Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3
    ... with God, affects medical choices, study finds , FRIDAY, Dec. 18 ... cancer could be just as important as taking care of their ... what was important to them at the end of their lives, ... being at peace with God, the study found. , "Medicine ...
    ... ... the nostrils help deliver scent molecules into the nose to the olfactory bulb, where ... From there, they are forwarded to areas of the central nervous system that mediate ... ...
    ... ... used across a range of enterprise activities , ... Washington, D.C. (PRWEB) December 18, 2009 -- Applied Predictive Technologies ... in the world, has signed an agreement to license APT,s Test & Learn Management System. ...
    ... Make your ... certificates and his own name-brand prescription-strength line of skincare products for Christmas. ... Denver, CO (PRWEB) December 17, ... your shopping done! Online gift certificates are now available at www.ravalmd.com and ...
    ... , , NEW YORK, Dec. 17 The Hebrew University ... Tropical Diseases has received a $5 million grant from the ... The project will be led by Professor Alon Warburg, ... and will include experts from Hebrew University,s Robert H. Smith ...
    ... , ... , EDF calls for dirty heating oil phase out by 2020 ... of the city,s heating oil soot pollution is created by burning the dirtiest ... City, according to a new report released today by ...
    Cached Medicine News:Health News:Spiritual Needs Rank High as Death From Cancer Nears 2Health News:Spiritual Needs Rank High as Death From Cancer Nears 3Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 2Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 3Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 4Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 5Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 6Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 7Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 8Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 9Health News:Banfield, The Pet Hospital Signs Agreement to License APT's Test & Learn Management System 2Health News:Banfield, The Pet Hospital Signs Agreement to License APT's Test & Learn Management System 3Health News:Streamline Your Holiday Shopping With Online Savings At Ravalmd.com 2Health News:Bill & Melinda Gates Foundation Grants $5 Million For Infectious Disease Research At The Hebrew University Of Jerusalem 2Health News:Bill & Melinda Gates Foundation Grants $5 Million For Infectious Disease Research At The Hebrew University Of Jerusalem 3Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 2Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 3Health News:9,000 NYC Buildings Burning Dirty Heating Oil Identified in New Report 4
    ... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...
    EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
    ... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
    ... Functional Vision, Quality of Vision and ... both target illumination and glare luminance ... results. Day/Night testing with/without glare and ... and all ANSI standards. All Light ...
    Medicine Products: